StrykerSYK
About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Employees: 52,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
20% more repeat investments, than reductions
Existing positions increased: 807 | Existing positions reduced: 670
18% more call options, than puts
Call options by funds: $512M | Put options by funds: $434M
0.14% less ownership
Funds ownership: 77.48% [Q1] → 77.34% (-0.14%) [Q2]
1% less funds holding
Funds holding: 1,948 [Q1] → 1,938 (-10) [Q2]
5% less capital invested
Capital invested by funds: $105B [Q1] → $100B (-$4.77B) [Q2]
7% less first-time investments, than exits
New positions opened: 134 | Existing positions closed: 144
4% less funds holding in top 10
Funds holding in top 10: 80 [Q1] → 77 (-3) [Q2]
Research analyst outlook
13 Wall Street Analysts provided 1 year price targets over the past 3 months
13 analyst ratings
BTIG Ryan Zimmerman 68% 1-year accuracy 23 / 34 met price target | 5%upside $383 | Buy Maintained | 14 Oct 2024 |
Truist Securities Richard Newitter 51% 1-year accuracy 19 / 37 met price target | 1%upside $370 | Hold Maintained | 14 Oct 2024 |
Evercore ISI Group Vijay Kumar 80% 1-year accuracy 24 / 30 met price target | 4%upside $380 | Outperform Maintained | 1 Oct 2024 |
Piper Sandler Matt O'Brien 37% 1-year accuracy 11 / 30 met price target | 4%upside $380 | Overweight Maintained | 10 Sept 2024 |
Wolfe Research Mike Polark 38% 1-year accuracy 3 / 8 met price target | 11%upside $405 | Outperform Initiated | 10 Sept 2024 |
Financial journalist opinion
Based on 11 articles about SYK published over the past 30 days
